Stempoint Capital Lp - Significant Ownership

Signature - Title
/s/ Sean C. Tan - Sean C. Tan, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Stempoint Capital Lp.

Notify me when Stempoint Capital Lp files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Stempoint Capital Lp

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 11.4% $11.9M $5.21M 1.02M +78.1% StemPoint Capital LP Jun 30, 2025
VTGN Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") 8.2% $4.8M 2.33M StemPoint Capital LP Dec 31, 2024
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.2% $3.38M 4M StemPoint Capital LP Sep 30, 2025

Schedules 13D/G Reported by Stempoint Capital Lp:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.